Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study.

导出 OA

翻译打印收藏纠错

作者： Ralph Th,Leijenaar ^[1] ; Marta,Bogowicz ^[2] ; Arthur,Jochems ^[1] ; Frank Jp,Hoebers ^[3] ; Frederik Wr,Wesseling ^[3] ; Sophie H,Huang ^[4] ; Biu,Chan ^[4] ; John N,Waldron ^[4] ; Brian,O'Sullivan ^[4] ; Derek,Rietveld ^[5] ; C Rene,Leemans ^[6] ; Ruud H,Brakenhoff ^[6] ; Oliver,Riesterer ^[2] ; Stephanie,Tanadini-Lang ^[2] ; Matthias,Guckenberger ^[2] ; Kristian,Ikenberg ^[7] ; Philippe,Lambin ^[1]

作者单位： 1 The D-Lab: Decision Support for Precision Medicine GROW - School for Oncology and Developmental Biology & MCCC Maastricht University Medical Centre+ Maastricht , Maastricht , Netherlands. ^[1] 2 Department of Radiation Oncology, University Hospital Zurich and University of Zurich , Zurich , Switzerland. ^[2] 3 Department of Radiation Oncology, GROW- School for Oncology and Developmental Biology, Maastricht University Medical Centre , Maastricht , Netherlands. ^[3] 4 Department of Radiation Oncology, Princess Margaret Cancer Center, University of Toronto , Toronto, Ontario , Canada. ^[4] 5 Department of Radiation Oncology, VU University Medical Center , Amsterdam , Netherlands. ^[5] 6 Department of Otolaryngology/Head and Neck Surgery, VU University Medical Center , Amsterdam , Netherlands. ^[6] 7 Institute of Pathology and Molecular Pathology, University Hospital Zurich and University of Zurich , Zurich , Switzerland. ^[7]